Logo
I

Inscripta, Inc.

85 employees

Inscripta is a life science technology company that develops digital genome engineering solutions.

Basic info

Industry

biotechnology research

Sectors

MADzymes
Biotechnology
Single-Cell Genomics
Life Science
Synthetic Biology
Digital Genome Engineering
Single Cell Writing
Gene Editing
Software
Health Care
Genome Editing
MAD7
CRISPR

Date founded

2015

Funding rounds raised

Total raised

$150M

from 25 investors over 25 rounds

I

Inscripta, Inc. raised $150M on April 5, 2021

Investors: D1 Capital Partners L.P., Foresite Capital and Durable Capital Partners LP

I

Inscripta, Inc. raised $125M on December 10, 2019

Investors: GoldenArc Capital, Paladin Capital Group, Venrock and Oak HC/FT

I

Inscripta, Inc. raised $20M on April 4, 2019

Investors: Paladin Capital Group, GoldenArc Capital, Foresite Capital, +ND Capital and Venrock

I

Inscripta, Inc. raised $30M on December 19, 2018

Investors: Paladin Capital Group, +ND Capital, Foresite Capital and Venrock

I

Inscripta, Inc. raised $56M on February 28, 2018

Investors: Paladin Capital Group, +ND Capital, Foresite Capital, Spruce Capital Partners, LLC and Venrock

I

Inscripta, Inc. raised $23M on February 28, 2017

Investors: Paladin Capital Group, Venrock, +ND Capital and Foresite Capital

FAQ